Michael D Waxman, MD | |
4300 Talbot Rd S Ste 300, Renton, WA 98055-6238 | |
(425) 228-6260 | |
(425) 228-6262 |
Full Name | Michael D Waxman |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 42 Years |
Location | 4300 Talbot Rd S Ste 300, Renton, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235217134 | NPI | - | NPPES |
00G584550 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | G58455 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Altru Hospital | Grand forks, ND | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Altru Health System | 1355251604 | 531 |
Four Corners Eye Clinic, Pc | 1658263173 | 6 |
News Archive
By 2025 some 500 million people will be living with osteoporosis, a chronic disease which weakens bones and leaves older adults at risk of a fragility fracture - a broken bone which typically occurs after a low-trauma fall. As a result, an estimated 13.5 million fragility fractures will occur worldwide.
A new study involving researchers at The University of Nottingham has revealed how children with an aggressive cancer predisposition syndrome experience a never before seen flood of mutations in their disease in just six months.
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection of medical conditions that include abdominal obesity, high blood pressure and high blood sugar levels.
Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced today the completion of their merger.
› Verified 6 days ago
Entity Name | Altru Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043309552 PECOS PAC ID: 1355251604 Enrollment ID: O20031111000714 |
News Archive
By 2025 some 500 million people will be living with osteoporosis, a chronic disease which weakens bones and leaves older adults at risk of a fragility fracture - a broken bone which typically occurs after a low-trauma fall. As a result, an estimated 13.5 million fragility fractures will occur worldwide.
A new study involving researchers at The University of Nottingham has revealed how children with an aggressive cancer predisposition syndrome experience a never before seen flood of mutations in their disease in just six months.
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection of medical conditions that include abdominal obesity, high blood pressure and high blood sugar levels.
Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced today the completion of their merger.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Michael D Waxman, MD 4300 Talbot Rd S Ste 300, Renton, WA 98055-6238 Ph: (425) 228-6260 | Michael D Waxman, MD 4300 Talbot Rd S Ste 300, Renton, WA 98055-6238 Ph: (425) 228-6260 |
News Archive
By 2025 some 500 million people will be living with osteoporosis, a chronic disease which weakens bones and leaves older adults at risk of a fragility fracture - a broken bone which typically occurs after a low-trauma fall. As a result, an estimated 13.5 million fragility fractures will occur worldwide.
A new study involving researchers at The University of Nottingham has revealed how children with an aggressive cancer predisposition syndrome experience a never before seen flood of mutations in their disease in just six months.
Researchers from the University of Sydney's Charles Perkins Centre have identified three specific molecules that accurately indicate insulin resistance, or pre-diabetes - a major predictor of metabolic syndrome, the collection of medical conditions that include abdominal obesity, high blood pressure and high blood sugar levels.
Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced today the completion of their merger.
› Verified 6 days ago
Mr. Jamison R Ridgeley, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1412 Sw 43rd St, Suite 206, Renton, WA 98057 Phone: 253-236-5720 Fax: 425-988-0168 | |
George J Ko, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4300 Talbot Rd S, Suite 300, Renton, WA 98055 Phone: 425-228-6262 Fax: 425-228-6260 | |
Dr. Jeanne Y Cubanski, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3915 Talbot Rd S, Ste 100, Renton, WA 98055 Phone: 425-690-3415 Fax: 425-690-9003 | |
Dr. Richard S. Dohoda, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3915 Talbot Rd S, Ste 100, Renton, WA 98055 Phone: 425-656-5345 Fax: 425-656-5349 | |
Dr. Joseph Walter King, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 900 Sw 16th St Ste 200, Renton, WA 98057 Phone: 425-525-2206 | |
Dr. Mark Barrett Walker, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1300 Sw 7th St, #105, Renton, WA 98057 Phone: 425-687-7700 Fax: 425-687-7703 |